Latest Drug Development Stories
GIA announces the release of a comprehensive global report on Orphan Drugs.
Managing Director of CompassX Group Kyle J.
CUPERTINO, Calif., April 30, 2015 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the first quarter of 2015.
Company showcase featuring Ed Addison to take place on Tuesday, May 12 from at 14:10 RESEARCH TRIANGLE PARK, N.C., April 30, 2015 /PRNewswire/ -- Ed Addison, CEO of Cloud Pharmaceuticals,
SAN DIEGO, April 30, 2015 /PRNewswire/ -- Finding genetic causes of progressive supranuclear palsy (PSP) is the goal of a joint research project announced today between Cypher Genomics and the
Conference Call and Webcast at 5:00 p.m.
SAN CARLOS, Calif., April 28, 2015 /PRNewswire/ -- Rosa & Co.
In a recent interview, Asymmetrex, LLC founder and director James L. Sherley, M.D., Ph.D.
RDIS(TM) and iOmics(TM) integration arcs across nonclinical, clinical and genomic biomarkers for targeted therapeutic drug development and stratified patient selection FOSTER CITY,
Designation would provide study protocol assistance and market exclusivity PETACH TIKVA, Israel, April 20, 2015 /PRNewswire/ -- Can-Fite
- a study of the individuals in a group of people within a specific context and their relationships.
- In rhetoric, the description of any one's personal appearance.